The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 02, 2010
Filed:
Jun. 09, 2006
Magda Asselin, Mahwah, NJ (US);
George Theodore Grosu, Pearl River, NY (US);
Annmarie Louise Sabb, Pennington, NJ (US);
Wayne Everett Childers, New Hope, PA (US);
Lisa Marie Havran, Florence, NJ (US);
Zhongqi Shen, Plainsboro, NJ (US);
James Jacob Bicksler, Titusville, NJ (US);
Dan Chaekoo Chong, Plainsboro, NJ (US);
Magda Asselin, Mahwah, NJ (US);
George Theodore Grosu, Pearl River, NY (US);
Annmarie Louise Sabb, Pennington, NJ (US);
Wayne Everett Childers, New Hope, PA (US);
Lisa Marie Havran, Florence, NJ (US);
Zhongqi Shen, Plainsboro, NJ (US);
James Jacob Bicksler, Titusville, NJ (US);
Dan Chaekoo Chong, Plainsboro, NJ (US);
Wyeth LLC, Madison, NJ (US);
Abstract
The present invention relates to novel piperazine-piperidine compounds. The compounds are useful as 5-HT1A binding agents, particularly as 5-HT1A receptor antagonists and agonists. These compounds are useful in treating central nervous system disorders, such as cognition disorders, anxiety disorders, depression and sexual dysfunction. The invention relates to compounds and pharmaceutically acceptable salts of formula (I'): wherein R-R, R, R, and n are set forth in the specification. The invention also relates to pharmaceutical compositions comprising compounds and pharmaceutically acceptable salts of formula (I′).